1.500
1.50 (0%)
As of Dec 24, 2024
Compass Therapeutics, Inc. [CMPX]
Source:
Company Overview
We are a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Our scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | 617-500-8099 |
Industry | manufacturing |
CEO | Vered Bisker-Leib |
Website | www.clinicaltrials.gov |